Japan Cold Pain Therapy Market Report 2022 to 2030

Japan Cold Pain Therapy Market Analysis

$ 3999

The Japan Cold Pain Therapy Market was valued at $137 Mn in 2022 and is predicted to grow at a CAGR of 5.7% from 2023 to 2030, to $213 Mn by 2030. The key drivers of this industry include the increasing prevalence of chronic pain disorders, growing consumer demand, and technological advancements in the therapeutics industry. The industry is primarily dominated by players such as Mentholatum, Eisai, Lion, Ossur, Romsons, Pfizer, Hisamitsu, and Johnson & Johnson among others.

ID: IN10JPPH310 CATEGORY: Pharmaceuticals GEOGRAPHY: Japan AUTHOR: Riddhi Solanki

Buy Now

Japan Cold Pain Therapy Market Analysis Executive Summary

The Japan Cold Pain Therapy Market is at around $137 Mn in 2022 and is projected to reach $213 Mn in 2030, exhibiting a CAGR of 5.7% during the forecast period.

Cryotherapy, known as cold pain therapy, is the use of cold substances to alleviate pain by activating the body's innate anti-inflammatory response and endorphin production, resulting in reduced inflammation, and discomfort. Ice packs are the most commonly available due to their low cost and ease of use, making them effective for treating pain caused by sprains, fractures, strains, tendinitis, and superficial tissue damage. Cold pain therapy is effective for both acute injuries like sprains, strains, and bruises, as well as chronic problems like arthritis and musculoskeletal disorders. Different product offerings include ice packs, cooling towels, compresses, wraps, and pads, as well as prescription-based motorized and non-motorized devices. Leading companies providing products for this therapy encompass Beiersdorf AG, DJO Global, Inc., Hisamitsu Pharmaceutical Co., Inc., Romsons Group of Industries, Polar Products, and Rapid Aid, among others.

Musculoskeletal disorders affect around 40% population accounting for about 42 Mn people in Japan. Market expansion is driven by factors such as the surge in the prevalence of chronic conditions, growing consumer demand, and technological advancements in the therapeutics industry. However, factors like competition from alternative approaches, market saturation, and regulatory challenges impede the market's growth and potential.

Market Dynamics

Market Growth Drivers

Rising prevalence of pain disorders: The increasing elderly population in Japan is resulting in a rise in chronic pain conditions such as arthritis, osteoporosis, and musculoskeletal disorders. MSDs affect more than 40% of the Japanese population accounting for 42 Mn people. This increases the demand for effective pain-relieving treatments like cryotherapy

Growing consumer demands: The key driver of market growth is the instant pain relief in muscle inflammation, swelling, and spasms provided by cryotherapy. This boosts their preference among customers for localized and targeted pain reduction benefits, contributing to market growth.

Technological advancements: The market is constantly evolving with advancements such as gel packs with improved temperature control, compression wraps with specific cooling, and wearables with inbuilt cooling technology. These developments improve the convenience, comfort, and effectiveness of cold treatment, leading to increased usage and market growth.

Market Restraints

Competition from conventional alternatives: Over-the-counter (OTC) analgesics such as ibuprofen and aspirin provide quick relief at a considerably cheaper cost. These readily available drugs have become routine pain treatment strategies, causing reluctance to adopt innovative treatments. A large majority of customers are unaware of the harmful side effects related to excessive use of traditional painkillers

Regulatory challenges: Navigating Japan's medical device regulatory environment can be complex and time-consuming, impeding the introduction of novel cold therapy products to the market. Furthermore, coverage of cold treatment items under insurance in Japan is inadequate, limiting accessibility for patients.

Market saturation: There are a number of dominant players in the market. Established players in the pain management industry benefit from high brand visibility and well-established distribution networks, making it difficult for new entrants.

Healthcare Policies and Regulatory Landscape

The main regulatory body overseeing drugs and pharmaceuticals in Japan is the Pharmaceuticals and Medical Devices Agency (PMDA). The PMDA is responsible for evaluating and ensuring the safety, efficacy, and quality of pharmaceuticals and medical devices. It operates under the Ministry of Health, Labour, and Welfare (MHLW) and plays a crucial role in the approval process for new drugs and medical products.

In Japan, the process of obtaining licensure for drugs typically involves several steps. First, the pharmaceutical company submits a New Drug Application (NDA) or a Marketing Authorization Application (MAA) to the PMDA, including comprehensive data from preclinical and clinical studies. T. If the application meets regulatory standards, the PMDA grants approval, allowing the pharmaceutical product to enter the Japanese market.

The regulatory environment for new entrants is stringent to protect public safety and the quality of healthcare products, making it critical for companies to comply with these criteria and submit thorough data in the clearance process for a successful new product launch

Competitive Landscape

Key Players

Mentholatum Company
Rohto Pharmaceutical
Eisai Co., Ltd
Hisamitsu Pharmaceutical
Lion Corporation
Romsons Group
DJO Global Inc
Johnson & Johnson
Ossur
Pfizer

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Japan Cold Pain Therapy Market Segmentation

By Therapy Type

Icepack
Chamber
Cryosurgery

By Product Type

OTC Products
Prescription Drugs

By Application

Dermatology
Oncology
Musculoskeletal disorders
Pain management
Sports medicine
Ophthalmology
Others

By End Users

Hospitals and clinics
Sports person
Adults
Others

By Distribution channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.